Q&A series examining industry challenges with Tim Morant and featuring Mike Happold

Insights from market expert Tony Laudato

Q&A series examining industry challenges with Tim Morant and featuring Dave Goehrke

Examining industry challenges with Tim Morant, Chief Risk Assessment Officer

An update on the success of our two-year partnership with GRAIL to promote early cancer detection in the US life insurance industry.

Our annual survey examines the individual and group life reinsurance market in the US and Canada.

Reinsurers provide know-how, perspective, advice, and solutions – that go beyond pure risk transfer.

A case study illustrating how Munich Re adds expertise and support across different stages of the life insurance product development lifecycle

Sean Kim, Head of M&A Solutions, discusses the pivotal role reinsurance in the life and annuity mergers and acquisitions (M&A) market.

Combination products providing both long-term care and life insurance coverage are a market opportunity for carriers.

What's the potential for GLP-1 agonists to reduce risk factors for heart disease?

In this series, we examine medical innovations impacting life and disability insurance, including new obesity drugs.

A study assessing the effectiveness of resting heart rate in stratifying the mortality risk profile of a U.S. insured population.

This paper's analysis is based on research conducted prior to the global pandemic and focuses on long-term mortality trends.

Analyzing the impact of cause-of-death

Munich Re’s Dr. Tim Meagher assesses studies on post-COVID-19 autoimmune disorders and their relevance to life insurance.

Dr. Tim Meagher reviews the evidence regarding increased morbidity and mortality risks for those with long-term COVID-19 infection and its relevance for insured populations

Dr. Tim Meagher examines the increase in both type 1 and type 2 diabetes that has occurred during the pandemic.

Claims professionals are well-positioned to provide insights and guidance tonavigate rapid change.

Dr. Tim Meagher provides an update on long Covid, with a particular focus on disease prevalence, disability, and risk factors.

Munich Re’s Dr. Tim Meagher assesses studies on post-COVID-19 autoimmune disorders and their relevance to life insurance.

Dr. Tim Meagher reviews the evidence regarding increased morbidity and mortality risks for those with long-term COVID-19 infection and its relevance for insured populations

Dr. Tim Meagher discusses the recent reclassification of pituitary adenomas as ‘pituitary neuroendocrine tumors'.

Dr. Tim Meagher explores the potential impact of generative AI on the medical profession.

Dr. Tim Meagher explores the potential impact of medical nomenclature changes.

With the rise of marijuana use, underwriters must understand the latest research and take a balanced approach to risk assessment.

We assess the implications on insuring this industry for employee benefits.

We performed a sensitivity analysis to estimate the mortality impact of extreme what-if marijuana-use scenarios.

alitheia integrates ExamOne LabPiQture as a data source to assess lab values and provide nuanced handling for more accurate automated decisioning

alitheia's team discusses assigning a medical severity to free-text application entries to use in automated decisioning.

A webinar on how insurers and reinsurers are reinventing underwriting processes to adapt to a new era of data and digitization.

How they work together

Findings from the EHR retro studies on the protective and operational value of EHRs in accelerated underwriting workflows

Findings from the EHR retro studies on the protective and operational value of EHRs in accelerated underwriting workflows

Findings from the EHR retro studies on the protective and operational value of EHRs in accelerated underwriting workflows

An update on the rapidly evolving adoption of electronic heath records (EHRs) in life insurance underwriting from the experts at Munich Re and Clareto.

Discover how Munich Re is making them easier to access and integrate.

Munich Re's experts explore how income validations shed light on disability claims

Obesity

Prevention

Could uncertainty be taken out of underwriting and pricing in the Group Benefits market through technology-enabled risk evaluation?

Multiple studies have shown that regular physical activity, including walking, decreases the risk or severity of many health issues.

What is the impact on employee benefits?

Musculoskeletal disease and injury is a risk we all face – and it’s on the rise

Creating a competitive edge

Technological advancements and the evolution of disability risk as it relates to occupational changes

A closer look at LLM accuracy, the developing regulatory landscape, and expected implementation costs. 

Dr. Tim Meagher explores the potential impact of generative AI on the medical profession.

Large language models could unlock difficult-to-access data and insights for underwriting and claims.

Can large language models help unlock unstructed data trapped in documents such as attending physician statements?

Creating a robust AI strategy for AI in insurance

EHRs 2.0: A new era of data-driven underwriting

Electronic Health Records podcast series

Electronic Health Records podcast series

Electronic Health Records podcast series

Munich Re analysis of UK Biobank data shows value in novel variables not typically used in life insurance underwriting.

Munich Re analysis of UK Biobank data shows value in novel variables not typically used in life insurance underwriting.

Obesity

How novel data from wearables (activity, sleep, heart rate) helps life insurance underwriting and wellness initiatives.

The first of four white papers sharing Munich Re insights from our study on wearable data use in accelerated underwriting.